Abstract:Objective: To investigate the clinicopathological characteristics, pathological diagnosis and prognosis of diffuse midline glioma (DMG) with H3K27 alteration in adults. Methods: Twenty cases of H3K27-altered adult DMG diagnosed in the First Affiliated Hospital of Nanjing Medical University were enrolled from 2017 to 2022. All cases were evaluated by clinical and imaging presentations, HE, immunohistochemical staining and molecular genetics; and the relevant literature was reviewed. Results: The ratio of male to female was 1∶1, and the median age was 53 years (range from 25 to 74 years); the tumors were located in the brainstem (3/20, 15%) and non-brainstem (17/20, 85%; three in thoracolumbar spinal cord and one in pineal region). The clinical manifestations were non-specific, mostly dizziness, headache, blurred vision, memory loss, low back pain, limb sensation and/or movement disorders, etc. Microscopically, the tumors showed infiltrative growth, with WHO grade 2 (3 cases), grade 3 (12 cases), and grade 4 (5 cases). The tumors showed astrocytoma-like and oligdendroglioma-like, pilocytic astrocytoma-like and epithelioid-like patterns. Immunohistochemically, the tumor cells were positive for GFAP, Olig2 and H3K27M, and H3K27me3 expression was variably lost. ATRX expression was lost in four cases, p53 was strongly positive in 11 cases. Ki-67 index was about 5%-70%. Molecular genetics showed p. k27m mutation in exon 1 of H3F3A gene in 20 cases; BRAF mutation in two cases: V600E and L597Q mutation in one case each. Follow up intervals ranged from 1 to 58 months, and the survival time for brainstem (6.0 months) and non-brainstem (30.4 months) tumors was significantly different (P<0.05). Conclusions: DMG with H3K27 alteration is uncommonly found in adults, mostly occurs in non-brainstem, and can present in adults of all ages. Owing to the wide histomorphologic features, mainly astrocytic differentiation, routine detection of H3K27me3 in midline glioma is recommended. Molecular testing should be performed on any suspected cases to avoid missed diagnosis. Concomitant BRAF L597Q mutation and PPM1D mutation are novel findings. The overall prognosis of this tumor is poor, with tumors located in the brainstem showing worse outcome.

Clinical Features and Prognosis of Diffuse Midline Glioma: A Series of 24 Cases

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma

Path-40. Clinical Characterization Of H3K27M-Mutant Gliomas

Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study

Spinal Cord Diffuse Midline Gliomas With H3 K27m-Mutant: Clinicopathological Features and Prognosis

National trends in the treatment of adult diffuse midline gliomas: a rare clinical scenario

Diffuse Midline Gliomas With Histone H3 K27M Mutation in Adults and Children A Retrospective Series of 164 Cases

Exploring MRI Characteristics of Brain Diffuse Midline Gliomas with the H3 K27M Mutation Using Radiomics

H3K27M Mutation Doesn't Mean Worse Prognosis in Old Patients

Diffuse midline glioma with <i>H3</i> K27M mutation in the spinal cord: A series of 33 cases

Clinical features and prognosis of spinal diffuse midline gliomas with H3K27M mutation

HGG-33. Prognostic Factors of H3K27M Histone-Mutant Diffuse Midline Gliomas in Patients ≤18Yrs

[Diffuse midline glioma with H3K27 alteration in adults: a clinicopathological analysis].

Surgical treatment of diffuse and multi-lobes involved glioma with the assistance of a multimodal technique

Spinal Cord Diffuse Midline Glioma With Histone H3 K27M Mutation in a Pediatric Patient

Slow-Growing Thalamic Glioma with Histone H3 Lysine 27-to-Methionine Mutation: 3-Year Follow-Up Before Surgical Intervention

MRI findings and analysis of diffuse midline glioma with H3 K27 mutation

Path-05. Clinical, Pathological And Molecular Disease Characteristics Of Diffuse Hemispheric Glioma, H3 G34-Mutant

The Biological Behavior of High-Grade Glioma in H3K27M Mutant Circumscribed Midline Gliomas

Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile

Differences in Survival Prognosticators Between Children and Adults with H3K27M‐mutant Diffuse Midline Glioma